Could you provide us with an introduction to the company as well as your operations in Shanghai, New York or Singapore? I created Acropolis Associates ten…
In Conversation
Overall health indicators have improved significantly in Indonesia in recent years. However, the country still faces many challenges and there are many areas in need of…
Your distinguished career in health research leadership and management has seen you through a variety of prestigious positions, not to mention the Order of Australia. Most…
Mensa Group is one of the leaders of the pharmaceutical industry in Indonesia. What inspired you to enter the industry and specifically why did you start…
You have recently taken over the position as head of AstraZeneca in South Korea, after several years working in China. What view did you have of…
You are one of the foreign multinational directors with most time in the Korean pharmaceutical industry, since 2003. What is your assessment of the direction the…
Which are the main transformations Dos Ni Roha has undergone in recent years? Dos Ni Roha has successfully taken advantage of its wide expertise in the…
What is KHIDI’s role in supporting the development of the Korean health industry? KHIDI performs three major roles in supporting the Korean health industry, which includes…
Previous to your current position as President of Pfizer Korea since 2004, you had been in the country between 1989 and 1993 as sales and marketing…
APL is part of Zuellig, the top Asian pharmaceutical distributor. How does being part of a large, regionally specialized player help APL here in Indonesia? Being…
Please introduce Handok Pharmaceuticals to our readers, and in particular how it has evolved through partnerships with different multinational companies throughout its history. Handok has developed…
Korea had a late start, but is now one of the global hot spots for clinical trials. How would you sum up and explain this quick…
